BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38345817)

  • 1. Risk of Dementia Among Patients With Diabetes in a Multidisciplinary, Primary Care Management Program.
    Wang K; Zhao S; Lee EK; Yau SZ; Wu Y; Hung CT; Yeoh EK
    JAMA Netw Open; 2024 Feb; 7(2):e2355733. PubMed ID: 38345817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic Control Over Multiple Decades and Dementia Risk in People With Type 2 Diabetes.
    Moran C; Lacy ME; Whitmer RA; Tsai AL; Quesenberry CP; Karter AJ; Adams AS; Gilsanz P
    JAMA Neurol; 2023 Jun; 80(6):597-604. PubMed ID: 37067815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Macrovascular and Microvascular Complications and All-Cause Mortality: A Population-Based Cohort Study.
    Tang EHM; Mak IL; Tse ETY; Wan EYF; Yu EYT; Chen JY; Chin WY; Chao DVK; Tsui WWS; Ha TKH; Wong CKH; Lam CLK
    Diabetes Care; 2022 Dec; 45(12):2871-2882. PubMed ID: 35972235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study.
    Jiao F; Fung CS; Wan YF; McGhee SM; Wong CK; Dai D; Kwok R; Lam CL
    Cardiovasc Diabetol; 2015 Aug; 14():105. PubMed ID: 26268736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses-A Population-Based and Propensity-Matched Cohort Study.
    Wan EYF; Fung CSC; Jiao FF; Yu EYT; Chin WY; Fong DYT; Wong CKH; Chan AKC; Chan KHY; Kwok RLP; Lam CLK
    Diabetes Care; 2018 Jan; 41(1):49-59. PubMed ID: 29138274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-Year Cost-effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM).
    Jiao FF; Fung CSC; Wan EYF; Chan AKC; McGhee SM; Kwok RLP; Lam CLK
    Diabetes Care; 2018 Feb; 41(2):250-257. PubMed ID: 29246949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study.
    Jiao FF; Fung CS; Wong CK; Wan YF; Dai D; Kwok R; Lam CL
    Cardiovasc Diabetol; 2014 Aug; 13():127. PubMed ID: 25142791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Hypertension Complications and Health Service Use 5 Years After Implementation of a Multicomponent Intervention.
    Yu EYT; Wan EYF; Mak IL; Chao DVK; Ko WWK; Leung M; Li YC; Liang J; Luk W; Wong MMY; Ha TKH; Chan AKC; Fong DYT; Lam CLK
    JAMA Netw Open; 2023 May; 6(5):e2315064. PubMed ID: 37223900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin A1c and Type 2 Diabetes Incidence Among Adolescents With Overweight and Obesity.
    Hoe FM; Darbinian JA; Greenspan LC; Lo JC
    JAMA Netw Open; 2024 Jan; 7(1):e2351322. PubMed ID: 38231515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
    Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank.
    Jiang G; Luk AO; Tam CHT; Lau ES; Ozaki R; Chow EYK; Kong APS; Lim CKP; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung SKS; Cheng YL; Chow CC; Pearson ER; So WY; Chan JCN; Ma RCW; ;
    PLoS Med; 2020 Jul; 17(7):e1003209. PubMed ID: 32722720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
    Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
    J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-year weight change after diabetes diagnosis and long-term incidence and sustainability of remission of type 2 diabetes in real-world settings in Hong Kong: An observational cohort study.
    Wu H; Yang A; Lau ESH; Zhang X; Fan B; Ma RCW; Kong APS; Chow E; So WY; Chan JCN; Luk AOY
    PLoS Med; 2024 Jan; 21(1):e1004327. PubMed ID: 38261560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual-Level and Clinic-Level Factors Associated With Achieving Glycemic Control in a Large Cohort of People With HIV in Care-Washington, DC.
    Happ LP; Monroe AK; Young HA; Ma Y; Greenberg AE; Horberg MA; Castel AD;
    J Acquir Immune Defic Syndr; 2020 Sep; 85(1):113-122. PubMed ID: 32541383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Mobile-Based Intervention for Glycemic Control in Patients With Type 2 Diabetes: Retrospective, Propensity Score-Matched Cohort Study.
    Li J; Sun L; Wang Y; Guo L; Li D; Liu C; Sun N; Xu Z; Li S; Jiang Y; Wang Y; Zhang S; Chen L
    JMIR Mhealth Uhealth; 2020 Mar; 8(3):e15390. PubMed ID: 32159518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Telemedicine Use and Glycemic Outcomes of Endocrinology Care for Patients With Type 2 Diabetes.
    Zupa MF; Vimalananda VG; Rothenberger SD; Lin JY; Ng JM; McCoy RG; Rosland AM
    JAMA Netw Open; 2023 Dec; 6(12):e2346305. PubMed ID: 38055278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes.
    Lacy ME; Gilsanz P; Karter AJ; Quesenberry CP; Pletcher MJ; Whitmer RA
    Diabetes Care; 2018 Nov; 41(11):2339-2345. PubMed ID: 30181165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a primary care multidisciplinary Risk Assessment and Management Program for patients with diabetes mellitus (RAMP-DM) over lifetime.
    Jiao F; Wan EYF; Fung CSC; Chan AKC; McGhee SM; Kwok RLP; Lam CLK
    Endocrine; 2019 Feb; 63(2):259-269. PubMed ID: 30155847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of a multidisciplinary risk assessment and management programme-diabetes mellitus (RAMP-DM) on patient-reported outcomes.
    Wan EY; Fung CS; Wong CK; Choi EP; Jiao FF; Chan AK; Chan KH; Lam CL
    Endocrine; 2017 Feb; 55(2):416-426. PubMed ID: 27699706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.